Federal Register, Volume 78 Issue 99 (Wednesday, May 22, 2013)[Federal Register Volume 78, Number 99 (Wednesday, May 22, 2013)]
[Notices]
[Page 30270]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12214]

-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-46-2013]

Foreign-Trade Zone (FTZ) 61--San Juan, Puerto Rico, Notification
of Proposed Production Activity, Janssen Ortho LLC (Pharmaceutical
Products Production), Gurabo, Puerto Rico

    The Puerto Rico Trade and Export Company, grantee of FTZ 61,
submitted a notification of proposed production activity to the FTZ
Board on behalf of Janssen Ortho LLC (Janssen), located in Gurabo,
Puerto Rico. The notification conforming to the requirements of the
regulations of the FTZ Board (15 CFR 400.22) was received on April 29,
2013.
    A separate application for subzone status at the Janssen facility
was submitted and will be processed under Section 400.31 of the FTZ
Board's regulations. The facility is used for the production of various
prescription and over-the-counter pharmaceutical products. Pursuant to
15 CFR 400.14(b), FTZ activity would be limited to the specific
foreign-status materials and components and specific finished products
listed in the submitted notification (as described below) and
subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt Janssen from customs
duty payments on the foreign status components used in export
production. On its domestic sales, Janssen would be able to choose the

duty rates during customs entry procedures that apply to various
prescription and over-the-counter pharmaceutical products, including:
Anti-cancer; anti-diabetic and immunosuppressive medicaments;
analgesics; antipyretic and anti-inflammatory agents; and, cough and
cold preparations (duty free) for the foreign status inputs noted
below. Customs duties also could possibly be deferred or reduced on
foreign status production equipment.
    The components and materials sourced from abroad include: Splenda
sucralose; cobicistate silicon dioxide; metformin; canagliflozin; and
darunavir ethanolate API (duty rates range from 86.2 cents/kg to 6.5%).
    Public comment is invited from interested parties. Submissions
shall be addressed to the FTZ Board's Executive Secretary at the
address below. The closing period for their receipt is July 1, 2013.
    A copy of the notification will be available for public inspection
at the Office of the Executive Secretary, Foreign-Trade Zones Board,
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW.,

Washington, DC 20230-0002, and in the ``Reading Room'' section of the
FTZ Board's Web site, which is accessible via www.trade.gov/ftz.

FOR FURTHER INFORMATION CONTACT: Diane Finver at Diane.Finver@trade.gov
or (202) 482-1367.

    Dated: May 16, 2013.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2013-12214 Filed 5-21-13; 8:45 am]
BILLING CODE 3510-DS-P